Sanofi (SNY) Projected to Post Earnings on Thursday

Sanofi (NASDAQ:SNY - Get Free Report) is expected to be posting its Q1 2025 quarterly earnings results before the market opens on Thursday, April 24th. Analysts expect the company to announce earnings of $0.87 per share and revenue of $9.79 billion for the quarter.

Sanofi (NASDAQ:SNY - Get Free Report) last posted its quarterly earnings results on Thursday, January 30th. The company reported $0.70 EPS for the quarter, meeting analysts' consensus estimates of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. On average, analysts expect Sanofi to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Sanofi Stock Up 1.8 %

SNY stock traded up $0.92 during midday trading on Tuesday, hitting $51.85. The company's stock had a trading volume of 4,414,134 shares, compared to its average volume of 2,360,951. The firm's 50-day moving average is $54.61 and its 200-day moving average is $52.11. The company has a current ratio of 1.46, a quick ratio of 1.14 and a debt-to-equity ratio of 0.15. Sanofi has a 12 month low of $45.80 and a 12 month high of $60.12. The company has a market cap of $130.99 billion, a PE ratio of 20.82, a P/E/G ratio of 1.01 and a beta of 0.57.

Sanofi Increases Dividend

The firm also recently declared an annual dividend, which will be paid on Thursday, June 12th. Stockholders of record on Friday, May 9th will be paid a $2.0369 dividend. The ex-dividend date of this dividend is Friday, May 9th. This represents a dividend yield of 3.1%. This is a boost from Sanofi's previous annual dividend of $1.48. Sanofi's payout ratio is currently 64.26%.

Institutional Trading of Sanofi

An institutional investor recently raised its position in Sanofi stock. Brighton Jones LLC raised its holdings in shares of Sanofi (NASDAQ:SNY - Free Report) by 52.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,420 shares of the company's stock after acquiring an additional 1,869 shares during the quarter. Brighton Jones LLC's holdings in Sanofi were worth $261,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 14.04% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Sanford C. Bernstein upgraded Sanofi to a "strong-buy" rating in a report on Thursday, January 30th. Deutsche Bank Aktiengesellschaft raised shares of Sanofi from a "sell" rating to a "hold" rating in a report on Thursday, January 30th. The Goldman Sachs Group assumed coverage on shares of Sanofi in a report on Friday, March 21st. They issued a "neutral" rating and a $65.00 target price on the stock. Finally, BNP Paribas started coverage on shares of Sanofi in a research note on Tuesday, April 15th. They set an "outperform" rating and a $65.00 target price for the company. Three analysts have rated the stock with a hold rating, two have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $63.33.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.